These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26986110)

  • 21. Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response.
    Trivedi PJ; Bruns T; Cheung A; Li KK; Kittler C; Kumagi T; Shah H; Corbett C; Al-Harthy N; Acarsu U; Coltescu C; Tripathi D; Stallmach A; Neuberger J; Janssen HL; Hirschfield GM
    J Hepatol; 2014 Jun; 60(6):1249-58. PubMed ID: 24548531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
    Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
    Alberts DS; Martínez ME; Hess LM; Einspahr JG; Green SB; Bhattacharyya AK; Guillen J; Krutzsch M; Batta AK; Salen G; Fales L; Koonce K; Parish D; Clouser M; Roe D; Lance P;
    J Natl Cancer Inst; 2005 Jun; 97(11):846-53. PubMed ID: 15928305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study.
    Lin TK; Chou P; Lin CH; Hung YJ; Jong GP
    PLoS One; 2018; 13(5):e0196713. PubMed ID: 29723231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
    Huang YW; Lee CL; Yang SS; Fu SC; Chen YY; Wang TC; Hu JT; Chen DS
    Am J Gastroenterol; 2016 Jul; 111(7):976-85. PubMed ID: 27166128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risk of colorectal cancer is related to frequent hospitalization of IBD in an Asian population: results from a nationwide study.
    Peng YC; Lin CL; Hsu WY; Chang CS; Yeh HZ; Liao SC; Kao CH
    QJM; 2015 Jun; 108(6):457-63. PubMed ID: 25362095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.
    Singh S; Khanna S; Pardi DS; Loftus EV; Talwalkar JA
    Inflamm Bowel Dis; 2013 Jul; 19(8):1631-8. PubMed ID: 23665966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.
    Thompson PA; Wertheim BC; Roe DJ; Ashbeck EL; Jacobs ET; Lance P; Martínez ME; Alberts DS
    Cancer Prev Res (Phila); 2009 Dec; 2(12):1023-30. PubMed ID: 19952360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance colonoscopy in elderly patients: a retrospective cohort study.
    Tran AH; Man Ngor EW; Wu BU
    JAMA Intern Med; 2014 Oct; 174(10):1675-82. PubMed ID: 25111954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.
    Ishizaki K; Iwaki T; Kinoshita S; Koyama M; Fukunari A; Tanaka H; Tsurufuji M; Sakata K; Maeda Y; Imada T; Chiba K
    Eur J Pharmacol; 2008 Jan; 578(1):57-64. PubMed ID: 17888421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
    Chen CH; Lin CL; Hsu CY; Kao CH
    QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
    Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
    Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ursodeoxycholic Acid for Treatment of Enlarged Polycystic Liver.
    Iijima T; Hoshino J; Suwabe T; Sumida K; Mise K; Kawada M; Imafuku A; Hayami N; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K; Ubara Y
    Ther Apher Dial; 2016 Feb; 20(1):73-8. PubMed ID: 26482029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer risk in patients with osteoporosis: a population-based cohort study.
    Sun LM; Liang JA; Lin CL; Lin MC; Chang NJ; Kao CH
    Curr Med Res Opin; 2017 Apr; 33(4):733-739. PubMed ID: 28044464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of liver cirrhosis on metastasis in colorectal cancer patients: a nationwide population-based cohort study.
    Chiou WY; Chang CM; Tseng KC; Hung SK; Lin HY; Chen YC; Su YC; Tseng CW; Tsai SJ; Lee MS; Li CY
    Jpn J Clin Oncol; 2015 Feb; 45(2):160-8. PubMed ID: 25378650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between atopic dermatitis and colorectal cancer risk: A nationwide cohort study.
    Chou WY; Lai PY; Hu JM; Hsu CH; Chen YC; Tian YF; You SL; Hsiao CW; Chou YC; Sun CA
    Medicine (Baltimore); 2020 Jan; 99(1):e18530. PubMed ID: 31895788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Tsan YT; Lee CH; Ho WC; Lin MH; Wang JD; Chen PC
    J Clin Oncol; 2013 Apr; 31(12):1514-21. PubMed ID: 23509319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gynecological malignancy risk in colorectal cancer survivors: A population-based cohort study.
    Chang WC; Muo CH; Liang JA; Sung FC; Kao CH
    Eur J Oncol Nurs; 2015 Oct; 19(5):473-8. PubMed ID: 25790918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoprevention of colorectal cancer with ursodeoxycholic acid: pro.
    Serfaty L
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S53-60. PubMed ID: 23141895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.